Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy

NCT01382498 is registered in ClinicalTrials.gov with Tabriz University as lead sponsor.

NCT NCT01382498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01382498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy
Lead sponsor
Tabriz University
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2009
Completion date
Not reported
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy